FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

François Estour

Research Profile

Phenomena

Chemicals & Drugs

Concepts & Ideas

Disorders

Mitochondrial Diseases

Co-author Network

Publications

TOP 3
François Estour; R K Kalakuntla; Olivier Lafont; R Le Provost; S Letort; S Müller; G Reiter; T Wille; Worek Franz; G Gouhier
Functionalized cyclodextrins bearing an alpha nucleophile--a promising way to degrade nerve agents.
Raman Kumar Kalakuntla; Olivier Lafont; Romain Le Provost; Sophie Letort; Susanne Müller; Georg Reiter; Horst Thiermann; Timo Wille; Worek Franz; Géraldine Gouhier; François Estour
New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (I). Synthesis and preliminary screening: evaluation of the detoxification using a half-quantitative enzymatic assay.
Susanne Müller; Horst Thiermann; Worek Franz; François Estour; Raman Kumar Kalakuntla; Olivier Lafont; Romain Le Provost; Georg Reiter
New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (II). In vitro detoxification of cyclosarin (GF): general screening and toxicokinetic aspects of OP scavengers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of François Estour (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: François Estour; R K Kalakuntla; Olivier Lafont; R Le Provost; S Letort; S Müller; G Reiter; T Wille; Worek Franz; G Gouhier
Functionalized cyclodextrins bearing an alpha nucleophile--a promising way to degrade nerve agents.
Chemico-biological interactions 2013;203(1):202-7.
2013: Raman Kumar Kalakuntla; Olivier Lafont; Romain Le Provost; Sophie Letort; Susanne Müller; Georg Reiter; Horst Thiermann; Timo Wille; Worek Franz; Géraldine Gouhier; François Estour
New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (I). Synthesis and preliminary screening: evaluation of the detoxification using a half-quantitative enzymatic assay.
Toxicology letters 2013;216(2-3):200-5.
2013: Susanne Müller; Horst Thiermann; Worek Franz; François Estour; Raman Kumar Kalakuntla; Olivier Lafont; Romain Le Provost; Georg Reiter
New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (II). In vitro detoxification of cyclosarin (GF): general screening and toxicokinetic aspects of OP scavengers.
Toxicology letters 2013;216(2-3):206-12.
2010: Aurélia Vergeade; Paul Mulder; Cathy Vendeville-Dehaudt; François Estour; Dominique Fortin; Renée Ventura-Clapier; Christian Thuillez; Christelle Monteil
Mitochondrial impairment contributes to cocaine-induced cardiac dysfunction: Prevention by the targeted antioxidant MitoQ.
Free radical biology & medicine 2010;49(5):748-56.
2007: François Estour; Vincent Ferranti; Christiane Chabenat; Emilie Toussaint; Hervé Galons; Olivier Lafont
Investigation of N-hydroxythalidomide in vitro stability and comparison to other N-substituted derivatives.
Journal of pharmaceutical and biomedical analysis 2007;45(2):237-42.
2007: Nicolas Masurier; Olivier Lafont; François Estour
[Substituted cyclodextrins: an example of biomimetic catalyzers].
Annales pharmaceutiques françaises 2007;65(2):126-33.
2006: Nicolas Masurier; François Estour; Bertrand Lefèvre; Bernard Brasme; Patrick Masson; Olivier Lafont
Improved access to 2-O-monobenzyl ethers of beta-cyclodextrin as precursors of catalysts for organophosphoryl esters hydrolysis.
Carbohydrate research 2006;341(7):935-40.
2005: Nicolas Masurier; François Estour; Marie-Thérèse Froment; Bertrand Lefèvre; Jean-Claude Debouzy; Bernard Brasme; Patrick Masson; Olivier Lafont
Synthesis of 2-substituted beta-cyclodextrin derivatives with a hydrolytic activity against the organophosphorylester paraoxon.
European journal of medicinal chemistry 2005;40(7):615-23.
2004: François Estour; Bernardin Akagah; J Ségrestaa; Philippe Vérité; Sabine Ménager; Olivier Lafont
[Porphyrin catalysts: a tool for preparation of metabolite models].
Annales pharmaceutiques françaises 2004;62(5):297-303.
2004: Bernardin Akagah; François Estour; Philippe Vérité; Pédro Lameiras; Mohammed Nour; Christian Cavé; Sabine Ménager; Olivier Lafont
Regio- and diastereocontrolled preparative oxidation of methyloctalones by a biomimetic porphyrin catalyst.
Chirality 2004;16(6):398-403.
2003: François Estour; Sabine Ménager; Bernardin Akagah; Olivier Lafont
Comparison of the efficiency of various methods for the synthesis of models of metabolites: example of 4a-methylhexahydronaphtalenones.
European journal of medicinal chemistry 2003;38(11-12):925-8.
2002: Jérôme Segrestaa; Philippe Vérité; François Estour; Sabine Ménager; Olivier Lafont
Improvement of a biomimetic porphyrin catalytic system by addition of acids.
Chemical & pharmaceutical bulletin 2002;50(6):744-8.